Quality of earnings, 13-week cash, the covenant runway on a leverage that ROSE through the capex cycle, working-capital unlock and the levers behind margin recovery and FY27 deleverage.
Net debt of ₹8,622 Cr sits at 4.35× EBITDA — UP from 3.73× through the ₹2,044 Cr capex cycle, leaving ≈ 1.15× of headroom to the 5.5× ceiling with interest of ₹777 Cr at ~2.55× cover. FY27 volume-led deleverage is the plan, and cash makes it real: DSO 92→75d releases ≈ ₹717 Cr, ₹700 Cr of AR is already >60d overdue, and cash of ₹1,231 Cr (≈ 4 weeks of cover) carries the resin cycle.
4 of 8 headline metrics improving vs prior · still off target: Revenue from Operations ₹15,401 Cr vs ₹16,500 Cr, EBITDA (Reported) ₹1,984 Cr vs ₹2,400 Cr, EBITDA Margin (Reported) 12.8% vs 15.0%
Hold FY27 capex ≤ ₹1,400 Cr, sweep OCF to debt as commissioned assets ramp — deleverage is the goal, not the achievement.
Net debt ₹8,622 Cr = 4.35× EBITDA, up from 3.73× (peak 4.52× in Q3); headroom to the 5.5× ceiling is ~1.15×.
Each day of DSO ties up ~₹42 Cr of working capital that could fund the FY27 debt paydown.
Closing the DSO gap releases ≈ ₹717 Cr of one-time cash straight into the ₹8,622 Cr net-debt stack; ₹700 Cr is already >60 days overdue and at collection risk.
Only ₹2,290 Cr of net-debt headroom (≈ 1.15×) remains to the 5.5× ceiling after leverage rose 3.73→4.52 (peak)→4.35×; FY27 needs capex ≤ ₹1,400 Cr and the OCF sweep as Egypt aseptic, Noida recycling and Mexico WPP commission — the path back toward 3.0×.
+₹74 Cr of FX/derivative gains sit inside reported EBITDA (4% of it) — the two-definition walk, disclosed each quarter.
Value-added growth (+18%) vs. films spread recovery vs. the FX swing (−₹84 → +₹74 Cr) vs. films realizations & cost-push (glut · GST 2.0 · freight).
Net weekly cash (bars) and ending cash (line) vs. ₹900 Cr minimum. Forecast trough: ₹1,096 Cr — resin-purchase and capex dips drive the sawtooth.
Net debt/EBITDA climbed 3.73× → 4.52× (Q3 peak) → 4.35× through the capex cycle, against the modeled 5.5× lender ceiling (CRISIL AA-/Stable). FY27 is the volume-led deleverage test — the trend, shown honestly.
Normalizing laggard divisions to a 70-day DSO releases ~₹726 Cr of one-time cash.
Concentrated in the global films book — overseas entities on Net-90 terms, LC-backed export documentation and the third-party chips desk — plus engineering & specialty programs where milestone billing lags the converting annuity. The fastest deleverage cash this fiscal year.
Flexible Packaging, Aseptic & Holography (+18.0% YoY) — the sticky CPG-contract book — and where EBITDA is generated.
Total AR ₹3,882 Cr — ties to DSO 92d on ₹15,401 Cr revenue
Overdue (>60d) = ₹700 Cr at collection risk.
Accounts ranked by DSO and credit/churn risk.
| Account | Revenue | DSO | Repeat | Credit/Churn |
|---|---|---|---|---|
| Converters & third-party chips | ₹3,121 Cr | 105d | 98% | High |
| Global CPGs — overseas films (150+ countries) | ₹6,180 Cr | 96d | 102% | Medium |
| L'Oréal | ₹330 Cr | 84d | 108% | Medium |
| Mondelēz | ₹620 Cr | 82d | 105% | Medium |
| P&G | ₹780 Cr | 80d | 106% | Low |
| PepsiCo | ₹850 Cr | 78d | 107% | Low |
| Nestlé | ₹760 Cr | 76d | 108% | Low |
| Coca-Cola | ₹700 Cr | 74d | 109% | Low |
| Tata Consumer | ₹480 Cr | 72d | 107% | Low |
| Britannia | ₹540 Cr | 70d | 106% | Low |
| Haldiram's | ₹420 Cr | 66d | 110% | Low |
| Amul | ₹620 Cr | 62d | 111% | Low |
EBITDA contribution, DSO normalization and program capture per operating line (at launch → current).
| Operating line / brand | Since | Revenue | EBITDA | DSO | Transform | Savings | Status |
|---|---|---|---|---|---|---|---|
| Flexible Packaging (Laminates & Pouches) | 1988 | ₹3,389 Cr | 12% → ₹542 Cr | 80→74d | 95% | 84% | Integrated |
| Flex Films (Global Films) | 1994 | ₹9,093 Cr | 18% → ₹955 Cr | 88→96d | 92% | 78% | Integrated |
| UFlex Engineering & Cylinders | 1995 | ₹448 Cr | 9% → ₹54 Cr | 96→88d | 84% | 70% | In progress |
| UFlex Holography & Security | 1999 | ₹380 Cr | 14% → ₹68 Cr | 66→60d | 90% | 80% | Integrated |
| Flexcure / Flexgreen (Chemicals & Inks) | 2004 | ₹791 Cr | 10% → ₹103 Cr | 62→58d | 86% | 72% | In progress |
| Asepto (Aseptic Liquid Packaging) | 2017 | ₹1,300 Cr | 6% → ₹234 Cr | 70→62d | 88% | 76% | In progress |
| F-TPM / F-WSP (Specialty Films) | 2019 | ₹420 Cr | 12% → ₹71 Cr | 90→82d | 80% | 66% | In progress |
| Asclepius (90% PCR Film) | 2023 | ₹240 Cr | 8% → ₹34 Cr | 84→78d | 72% | 58% | In progress |
Resin (PTA/MEG, crude-linked), foil, paperboard, power & freight spend, DPO (working-capital lever), delivery and risk.
| Supplier | Category | Spend | DPO | OTIF | Score | Risk |
|---|---|---|---|---|---|---|
| PET resin & chips inputs — PTA / MEG (crude-linked) | Resins (primary input) | ₹3,600 Cr | 45d | 93% | 82 | High |
| PP granules & specialty polymers (BOPP / CPP / WPP) | Resins & polymers | ₹1,500 Cr | 50d | 94% | 84 | Medium |
| Aluminium foil, metallizing & coating inputs | Foil & coatings | ₹900 Cr | 55d | 92% | 85 | Medium |
| Ocean & inland freight / logistics | Freight & logistics | ₹850 Cr | 42d | 88% | 80 | High |
| Power & fuel (9-country plants) | Power & fuel | ₹739 Cr | 40d | 96% | 83 | Medium |
| Paperboard & aseptic laminate inputs | Paperboard (aseptic) | ₹450 Cr | 48d | 95% | 86 | Low |